Did you know that high BP management can be done without taking pills? Did you know that lowering blood pressures can be done through Chaksu Seeds? So what are Chaksu Seeds, what are Chaksu Seeds benefits and how can they help in keeping your blood pressure under a check? Let’s find out if they are any good for lowering blood pressure!
In the realm of natural health remedies, Chaksu seeds, known scientifically as Cassia Absus and belonging to the Caesalpiniaceae family, are gaining prominence for their effectiveness in managing high blood pressure without the need for conventional medications. This surge in popularity has prompted a significant interest among farmers and producers of Ayurvedic medicines towards the […]
The U.S. Food and Drug Administration (FDA) has granted approval to Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd., for the Paradise Ultrasound Renal Denervation (RDN) system. This groundbreaking technology presents a new adjunctive option for the treatment of patients whose hypertension is not adequately controlled by traditional means. A New […]
BaroPace Inc., a medical technology company focused on developing pacemaker regulation techniques based on blood pressure, has been granted approval by the Central Drugs Standard Control Organisation (CDSCO) of India to carry out its clinical trial, RelieveHFpEF-II, in the country. The RelieveHFpEF-II trial is a randomized, cross-over design, First-in-Human, Early Feasibility Study that employs BaroPace’s […]
Granules India Limited announced its receipt of US Food and Drug Administration (FDA) approval for its Abbreviated New Drug Application (ANDA) of Metoprolol Succinate Extended-Release Tablets USP, 25 mg, 50 mg, 100 mg, and 200 mg. The approval positions Granules India more strongly within the approximately $321 million US market for this particular medication. The […]
OMRON Healthcare, a Japanese manufacturer and distributor of blood pressure monitors and cardiovascular disease prevention services, has announced its plans to launch operations in Chennai, India. The company will set up a blood pressure monitor manufacturing facility at Origins by Mahindra, located in the Mahindra Industrial Park Chennai Limited (MIPCL). MIPCL is a joint venture […]
Glenmark Pharmaceuticals said that its US-based subsidiary has launched Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) SingleDose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose Vials. The launched product is the generic version of Validus Pharmaceuticals’ Bumex Injection, 0.25 mg/mL. Bumex is indicated for the treatment of swelling and high blood pressure. As per […]
Zydus Lifesciences Limited (previously Cadila Healthcare Limited) has bagged final approval for Sildenafil for Oral Suspension USP 10 mg/ml, its generic for Revatio, from the United States Food and Drug Administration (FDA). According to Zydus Lifesciences, Sildenafil for oral suspension is approved for the treatment of high blood pressure in the lungs (pulmonary hypertension). By […]
US-based digital healthcare company PyrAmes, which is focused on manufacturing continuous blood pressure monitoring products, has raised $6 million in a Series A round. The funding round was led by GSR Ventures, and had seen participation from Keytone Ventures, and XTX Ventures among other investors. Xina Quan – Co-Founder and CEO of PyrAmes said: “We […]
According to the research, it is revealed that consuming berry juice for long term can benefit hypertension patients to lower blood pressure. The study also revealed that it also improves the functioning of blood vessels. Many studies stated that food items with polyphenol can reduce the risk of cardiovascular diseases. Berries like lingonberry, cranberry, bilberry […]
Arena Pharmaceuticals has secured that fast track designation for its drug candidate APD418 from the US Food and Drug Administration (FDA) for the treatment of decompensated heart failure (DHF). APD418 is a β3-adrenergic receptor (AdrR) antagonist and cardiac myotrope. According to the San Diego-based biopharma company, APD418 is a selective antagonist that has been designed […]
